HKPD Cellyan Biotechnology Co., Ltd

Healthcare

$0.54+1.87%ClosedMarket Cap: $5.9M

As of 2026-05-26

Valuation

P/E (TTM)

5.24

PEG

—

P/B

0.96

P/S

0.29

EV/EBITDA

6.17

DCF Value

$0.63

FCF Yield

7.1%

Div Yield

0.0%

Margins & Returns

Gross Margin

11.9%

Operating Margin

0.7%

Net Margin

-0.1%

ROE

-0.6%

ROA

-0.3%

ROIC

-1.3%

Income Statement

Periods shown are fiscal year quarters (may differ from calendar year)

Period	Revenue	Gross Margin	Operating Income	Net Income	EPS	Dividend
Q4 null	$9.2M	5.5%	$-895.0K	$-855.6K	$—	—
FY null	$20.3M	11.9%	$132.0K	$-27.1K	$—	—
Q2 null	$11.1M	17.2%	$1.0M	$828.6K	$—	—
Q4 null	$9.7M	23.0%	$1.3M	$1.1M	$—	—
FY null	$16.7M	21.3%	$1.6M	$1.3M	$—	—
Q2 null	$7.0M	19.1%	$308.8K	$249.0K	$—	—
FY null	$12.6M	21.8%	$1.0M	$998.2K	$—	—